Literature DB >> 12546688

Physiological role of AMP-activated protein kinase (AMPK): insights from knockout mouse models.

B Viollet1, F Andreelli, S B Jørgensen, C Perrin, D Flamez, J Mu, J F P Wojtaszewski, F C Schuit, M Birnbaum, E Richter, R Burcelin, S Vaulont.   

Abstract

AMP-activated protein kinase (AMPK) is viewed as a fuel sensor for glucose and lipid metabolism. To understand better the physiological role of the catalytic AMPK subunit isoforms, we generated two knockout mouse models with the alpha1 (AMPK alpha 1(-/-)) and alpha 2 (AMPK alpha 2(-/-)) catalytic subunit genes deleted. No defect in glucose homoeostasis was observed in AMPK alpha 1(-/-) mice. On the other hand, AMPK alpha 2(-/-) mice presented high plasma glucose levels and low plasma insulin concentrations in the fed period and during the glucose tolerance test. Nevertheless, in isolated AMPK alpha 2(-/-) pancreatic islets, glucose-stimulated insulin secretion was not affected. Surprisingly, AMPK alpha 2(-/-) mice were insulin-resistant and had reduced muscle glycogen synthesis as assessed in vivo by the hyperinsulinaemic euglycaemic clamp procedure. Reduction of insulin sensitivity and glycogen synthesis were not dependent on the lack of AMPK in skeletal muscle, since mice expressing a dominant inhibitory mutant of AMPK in skeletal muscle were not affected and since insulin-stimulated glucose transport in incubated muscles in vitro was normal in AMPK alpha 2(-/-) muscles. Furthermore, AMPK alpha 2(-/-) mice have a higher sympathetic tone, as shown by increased catecholamine urinary excretion. Increased adrenergic tone could explain both decreased insulin secretion and insulin resistance observed in vivo in AMPK alpha 2(-/-) mice. We suggest that the alpha2 catalytic subunit of AMPK plays a major role as a fuel sensor by modulating the activity of the autonomous nervous system in vivo.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12546688     DOI: 10.1042/bst0310216

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  86 in total

1.  APPL1 mediates adiponectin-stimulated p38 MAPK activation by scaffolding the TAK1-MKK3-p38 MAPK pathway.

Authors:  Xiaoban Xin; Lijun Zhou; Caleb M Reyes; Feng Liu; Lily Q Dong
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-10-26       Impact factor: 4.310

2.  Postnatal induction of muscle fatty acid oxidation in mice differing in propensity to obesity: a role of pyruvate dehydrogenase.

Authors:  Jana Buresova; Petra Janovska; Ondrej Kuda; Jana Krizova; Inge Romijnders-van der Stelt; Jaap Keijer; Hana Hansikova; Martin Rossmeisl; Jan Kopecky
Journal:  Int J Obes (Lond)       Date:  2018-12-11       Impact factor: 5.095

3.  Early ALS-type gait abnormalities in AMP-dependent protein kinase-deficient mice suggest a role for this metabolic sensor in early stages of the disease.

Authors:  Maxime Vergouts; Claudia Marinangeli; Caroline Ingelbrecht; Geraldine Genard; Olivier Schakman; Anthony Sternotte; André-Guilhem Calas; Emmanuel Hermans
Journal:  Metab Brain Dis       Date:  2015-07-09       Impact factor: 3.584

4.  Suppression of the JNK pathway by induction of a metabolic stress response prevents vascular injury and dysfunction.

Authors:  Eberhard Schulz; Jörn Dopheide; Swenja Schuhmacher; Shane R Thomas; Kai Chen; Andreas Daiber; Philip Wenzel; Thomas Münzel; John F Keaney
Journal:  Circulation       Date:  2008-09-23       Impact factor: 29.690

Review 5.  Role of AMP-activated protein kinase in metabolic depression in animals.

Authors:  Mark H Rider
Journal:  J Comp Physiol B       Date:  2015-07-15       Impact factor: 2.200

6.  Genome-wide RNAi Screen for Fat Regulatory Genes in C. elegans Identifies a Proteostasis-AMPK Axis Critical for Starvation Survival.

Authors:  Christopher M Webster; Elizabeth C Pino; Christopher E Carr; Lianfeng Wu; Ben Zhou; Lucydalila Cedillo; Michael C Kacergis; Sean P Curran; Alexander A Soukas
Journal:  Cell Rep       Date:  2017-07-18       Impact factor: 9.423

Review 7.  Effects of AMP-activated protein kinase in cerebral ischemia.

Authors:  Jun Li; Louise D McCullough
Journal:  J Cereb Blood Flow Metab       Date:  2009-12-16       Impact factor: 6.200

8.  The CAMKK2-AMPK kinase pathway mediates the synaptotoxic effects of Aβ oligomers through Tau phosphorylation.

Authors:  Georges Mairet-Coello; Julien Courchet; Simon Pieraut; Virginie Courchet; Anton Maximov; Franck Polleux
Journal:  Neuron       Date:  2013-04-10       Impact factor: 17.173

9.  Loss of AMP-activated protein kinase alpha2 subunit in mouse beta-cells impairs glucose-stimulated insulin secretion and inhibits their sensitivity to hypoglycaemia.

Authors:  Craig Beall; Kaisa Piipari; Hind Al-Qassab; Mark A Smith; Nadeene Parker; David Carling; Benoit Viollet; Dominic J Withers; Michael L J Ashford
Journal:  Biochem J       Date:  2010-07-15       Impact factor: 3.857

10.  Acute inhibition of selected membrane-proximal mouse T cell receptor signaling by mitochondrial antagonists.

Authors:  Kwangmi Kim; Lin Wang; Inkyu Hwang
Journal:  PLoS One       Date:  2009-11-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.